↓ Skip to main content

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia

Overview of attention for article published in Cardiovascular Drugs and Therapy, February 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
72 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
Published in
Cardiovascular Drugs and Therapy, February 2019
DOI 10.1007/s10557-019-06852-6
Pubmed ID
Authors

Henry N. Ginsberg, Jaakko Tuomilehto, G. Kees Hovingh, Bertrand Cariou, Raul D. Santos, Alan S. Brown, Santosh K. Sanganalmath, Andrew Koren, Desmond Thompson, Frederick J. Raal

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 14%
Researcher 8 11%
Student > Master 6 8%
Other 5 7%
Student > Ph. D. Student 5 7%
Other 10 14%
Unknown 28 39%
Readers by discipline Count As %
Medicine and Dentistry 27 38%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Biochemistry, Genetics and Molecular Biology 4 6%
Veterinary Science and Veterinary Medicine 1 1%
Arts and Humanities 1 1%
Other 2 3%
Unknown 31 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2019.
All research outputs
#6,311,196
of 23,128,387 outputs
Outputs from Cardiovascular Drugs and Therapy
#152
of 701 outputs
Outputs of similar age
#133,553
of 439,824 outputs
Outputs of similar age from Cardiovascular Drugs and Therapy
#4
of 17 outputs
Altmetric has tracked 23,128,387 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 701 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,824 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.